Donat SM - Search Results

1

Association between urinary cytology and pathology for nontransitional cell malignancies of the urinary tract.

Raj GV, Bochner BH, Vickers A, Teper E, Lin O, Donat SM, Herr H, Dalbagni G. Raj GV, et al. Among authors: donat sm. J Urol. 2006 Jun;175(6):2038-41; discussion 2041. doi: 10.1016/S0022-5347(06)00279-5. J Urol. 2006. PMID: 16697796

2

Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Herr HW, et al. Among authors: donat sm. J Urol. 2002 Mar;167(3):1295-8. J Urol. 2002. PMID: 11832716

3

Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.

Herr HW, Donat SM, Dalbagni G. Herr HW, et al. Among authors: donat sm. J Urol. 2002 Sep;168(3):978-80. doi: 10.1016/S0022-5347(05)64555-7. J Urol. 2002. PMID: 12187203

4

Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence.

Yossepowitch O, Dalbagni G, Golijanin D, Donat SM, Bochner BH, Herr HW, Fair WR, Russo P. Yossepowitch O, et al. Among authors: donat sm. J Urol. 2003 Jan;169(1):177-81. doi: 10.1016/S0022-5347(05)64062-1. J Urol. 2003. PMID: 12478130

5

Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.

Donat SM, Bayuga S, Herr HW, Berwick M. Donat SM, et al. J Urol. 2003 Nov;170(5):1777-80. doi: 10.1097/01.ju.0000091803.35049.da. J Urol. 2003. PMID: 14532774

6

Frequency of NY-ESO-1 and LAGE-1 expression in bladder cancer and evidence of a new NY-ESO-1 T-cell epitope in a patient with bladder cancer.

Sharma P, Gnjatic S, Jungbluth AA, Williamson B, Herr H, Stockert E, Dalbagni G, Donat SM, Reuter VE, Santiago D, Chen YT, Bajorin DF, Old LJ. Sharma P, et al. Among authors: donat sm. Cancer Immun. 2003 Dec 18;3:19. Cancer Immun. 2003. PMID: 14680360

7

Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cm.

Donat SM, North A, Dalbagni G, Herr HW. Donat SM, et al. J Urol. 2004 Feb;171(2 Pt 1):636-9. doi: 10.1097/01.ju.0000103100.22951.5e. J Urol. 2004. PMID: 14713776

8

Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.

Konety BR, Eastham JA, Reuter VE, Scardino PT, Donat SM, Dalbagni G, Russo P, Herr HW, Schwartz L, Kantoff PW, Scher H, Kelly WK. Konety BR, et al. Among authors: donat sm. J Urol. 2004 Feb;171(2 Pt 1):709-13. doi: 10.1097/01.ju.0000108122.36893.5a. J Urol. 2004. PMID: 14713792 Clinical Trial.

9

Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.

Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, Dalbagni G, Sogani PC. Holzbeierlein JM, et al. Among authors: donat sm. J Urol. 2004 Sep;172(3):878-81. doi: 10.1097/01.ju.0000135530.59860.7d. J Urol. 2004. PMID: 15310988

10

Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.

Mullerad M, Russo P, Golijanin D, Chen HN, Tsai HH, Donat SM, Bochner BH, Herr HW, Sheinfeld J, Sogani PC, Kattan MW, Dalbagni G. Mullerad M, et al. Among authors: donat sm. J Urol. 2004 Dec;172(6 Pt 1):2177-81. doi: 10.1097/01.ju.0000144505.40915.98. J Urol. 2004. PMID: 15538226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters